Listed

Indivior Pharmaceuticals, Inc.

INDVNasdaqCIK 1625297HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$356.0m, Q3 FY2026
Operating income$180.0m, Q3 FY2026
Net income$137.0m, Q3 FY2026
Indivior Pharmaceuticals, Inc., income statement, quarterly
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Revenue$m284Revenue, period not labelled, three months to 2024-03-31$284.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure299Revenue, period not labelled, three months to 2024-06-30$299.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-31, accession 0001625297-25-000050.Report this figure307Revenue, period not labelled, three months to 2024-09-30$307.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure299Revenue, Q4 FY2024, three months to 2024-12-31$299.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure266Revenue, Q1 FY2025, three months to 2025-03-31$266.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure302Revenue, Q2 FY2025, three months to 2025-06-30$302.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure314Revenue, Q3 FY2025, three months to 2025-09-30$314.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure358Revenue, Q4 FY2025, three months to 2025-12-31$358.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure317Revenue, Q1 FY2026, three months to 2026-03-31$317.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure343Revenue, Q2 FY2026, three months to 2026-06-30$343.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure356Revenue, Q3 FY2026, three months to 2026-09-30$356.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Cost of revenue$m38.0Cost of revenue, period not labelled, three months to 2024-03-31$38.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure79.0Cost of revenue, period not labelled, three months to 2024-06-30$79.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-31, accession 0001625297-25-000050.Report this figure66.0Cost of revenue, period not labelled, three months to 2024-09-30$66.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure48.0Cost of revenue, Q4 FY2024, three months to 2024-12-31$48.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure44.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$44.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure52.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$52.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure83.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$83.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure67.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$67.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure40.0Cost of revenue, Q1 FY2026, three months to 2026-03-31$40.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure50.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$50.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure51.0Cost of revenue, Q3 FY2026, three months to 2026-09-30$51.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Gross profit$m246Gross profit, period not labelled, three months to 2024-03-31$246.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure220Gross profit, period not labelled, three months to 2024-06-30$220.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-07-31, accession 0001625297-25-000050.Report this figure241Gross profit, period not labelled, three months to 2024-09-30$241.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure250Gross profit, Q4 FY2024, three months to 2024-12-31$250.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure221Gross profit, Q1 FY2025, three months to 2025-03-31$221.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure250Gross profit, Q2 FY2025, three months to 2025-06-30$250.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure230Gross profit, Q3 FY2025, three months to 2025-09-30$230.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure292Gross profit, Q4 FY2025, three months to 2025-12-31$292.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure277Gross profit, Q1 FY2026, three months to 2026-03-31$277.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure294Gross profit, Q2 FY2026, three months to 2026-06-30$294.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure305Gross profit, Q3 FY2026, three months to 2026-09-30$305.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Selling, general and administrative$m143Selling, general and administrative, period not labelled, three months to 2024-03-31$143.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure152Selling, general and administrative, period not labelled, three months to 2024-06-30$152.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure142Selling, general and administrative, period not labelled, three months to 2024-09-30$142.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure175Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$175.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure133Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$133.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure158Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$158.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure154Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$154.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure189Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$189.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure124Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$124.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure122Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$122.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure119Selling, general and administrative, Q3 FY2026, three months to 2026-09-30$119.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Operating income$m75.0Operating income, period not labelled, three months to 2024-03-31$75.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure(118)Operating income, period not labelled, three months to 2024-06-30−$118.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure35.0Operating income, period not labelled, three months to 2024-09-30$35.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure46.0Operating income, Q4 FY2024, three months to 2024-12-31$46.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure66.0Operating income, Q1 FY2025, three months to 2025-03-31$66.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure72.0Operating income, Q2 FY2025, three months to 2025-06-30$72.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure43.0Operating income, Q3 FY2025, three months to 2025-09-30$43.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure81.0Operating income, Q4 FY2025, three months to 2025-12-31$81.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure137Operating income, Q1 FY2026, three months to 2026-03-31$137.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure160Operating income, Q2 FY2026, three months to 2026-06-30$160.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure180Operating income, Q3 FY2026, three months to 2026-09-30$180.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Interest expense$m9.0Interest expense, period not labelled, three months to 2024-03-31$9.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure9.0Interest expense, period not labelled, three months to 2024-06-30$9.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-07-31, accession 0001625297-25-000050.Report this figure11.0Interest expense, period not labelled, three months to 2024-09-30$11.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure13.0Interest expense, Q4 FY2024, three months to 2024-12-31$13.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure12.0Interest expense, Q1 FY2025, three months to 2025-03-31$12.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure15.0Interest expense, Q2 FY2025, three months to 2025-06-30$15.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure12.0Interest expense, Q3 FY2025, three months to 2025-09-30$12.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure6.0Interest expense, Q4 FY2025, three months to 2025-12-31$6.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure7.0Interest expense, Q1 FY2026, three months to 2026-03-31$7.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure2.0Interest expense, Q2 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure2.0Interest expense, Q3 FY2026, three months to 2026-09-30$2.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Income tax$m11.0Income tax, period not labelled, three months to 2024-03-31$11.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure(23.0)Income tax, period not labelled, three months to 2024-06-30−$23.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure8.0Income tax, period not labelled, three months to 2024-09-30$8.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure17.0Income tax, Q4 FY2024, three months to 2024-12-31$17.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure11.0Income tax, Q1 FY2025, three months to 2025-03-31$11.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure44.0Income tax, Q2 FY2025, three months to 2025-06-30$44.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure(5.0)Income tax, Q3 FY2025, three months to 2025-09-30−$5.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure(21.0)Income tax, Q4 FY2025, three months to 2025-12-31−$21.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure26.0Income tax, Q1 FY2026, three months to 2026-03-31$26.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure38.0Income tax, Q2 FY2026, three months to 2026-06-30$38.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure45.0Income tax, Q3 FY2026, three months to 2026-09-30$45.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Net income$m61.0Net income, period not labelled, three months to 2024-03-31$61.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure(97.0)Net income, period not labelled, three months to 2024-06-30−$97.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure22.0Net income, period not labelled, three months to 2024-09-30$22.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure21.0Net income, Q4 FY2024, three months to 2024-12-31$21.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure47.0Net income, Q1 FY2025, three months to 2025-03-31$47.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure18.0Net income, Q2 FY2025, three months to 2025-06-30$18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure42.0Net income, Q3 FY2025, three months to 2025-09-30$42.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure102Net income, Q4 FY2025, three months to 2025-12-31$102.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure89.0Net income, Q1 FY2026, three months to 2026-03-31$89.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure122Net income, Q2 FY2026, three months to 2026-06-30$122.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure137Net income, Q3 FY2026, three months to 2026-09-30$137.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Diluted EPS$ per share0.45Diluted EPS, period not labelled, three months to 2024-03-31$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure(0.72)Diluted EPS, period not labelled, three months to 2024-06-30−$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-31, accession 0001625297-25-000050.Report this figure0.16Diluted EPS, period not labelled, three months to 2024-09-30$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figurenot reported0.38Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure0.14Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure0.33Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figurenot reported0.69Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.69 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure0.98Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure1.12Diluted EPS, Q3 FY2026, three months to 2026-09-30$1.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Basic EPS$ per share0.45Basic EPS, period not labelled, three months to 2024-03-31$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure(0.72)Basic EPS, period not labelled, three months to 2024-06-30−$0.72 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-31, accession 0001625297-25-000050.Report this figure0.16Basic EPS, period not labelled, three months to 2024-09-30$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figurenot reported0.38Basic EPS, Q1 FY2025, three months to 2025-03-31$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure0.15Basic EPS, Q2 FY2025, three months to 2025-06-30$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure0.34Basic EPS, Q3 FY2025, three months to 2025-09-30$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figurenot reported0.71Basic EPS, Q1 FY2026, three months to 2026-03-31$0.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure1.02Basic EPS, Q2 FY2026, three months to 2026-06-30$1.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure1.16Basic EPS, Q3 FY2026, three months to 2026-09-30$1.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure

Balance sheet

Cash and equivalents$305.0m, Q3 FY2026
Long-term debt$0, Q3 FY2026
Shareholders' equity−$60.0m, Q3 FY2026
Indivior Pharmaceuticals, Inc., balance sheet, quarterly
Line itemUnitFY20232023-12-31period not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Cash and equivalents$m316Cash and equivalents, FY2023, at 2023-12-31$316.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-03, accession 0001625297-25-000016.Report this figurenot reportednot reportednot reported319Cash and equivalents, FY2024, at 2024-12-31$319.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure372Cash and equivalents, Q1 FY2025, at 2025-03-31$372.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure510Cash and equivalents, Q2 FY2025, at 2025-06-30$510.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-31, accession 0001625297-25-000050.Report this figure445Cash and equivalents, Q3 FY2025, at 2025-09-30$445.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure195Cash and equivalents, FY2025, at 2025-12-31$195.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure175Cash and equivalents, Q1 FY2026, at 2026-03-31$175.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure222Cash and equivalents, Q2 FY2026, at 2026-06-30$222.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure305Cash and equivalents, Q3 FY2026, at 2026-09-30$305.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Current assets$m1,257Current assets, FY2023, at 2023-12-31$1.26bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figurenot reportednot reportednot reported827Current assets, FY2024, at 2024-12-31$827.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure883Current assets, Q1 FY2025, at 2025-03-31$883.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure951Current assets, Q2 FY2025, at 2025-06-30$951.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-31, accession 0001625297-25-000050.Report this figure922Current assets, Q3 FY2025, at 2025-09-30$922.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure652Current assets, FY2025, at 2025-12-31$652.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure667Current assets, Q1 FY2026, at 2026-03-31$667.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure725Current assets, Q2 FY2026, at 2026-06-30$725.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure800Current assets, Q3 FY2026, at 2026-09-30$800.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Total assets$m1,758Total assets, FY2023, at 2023-12-31$1.76bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figurenot reportednot reportednot reported1,316Total assets, FY2024, at 2024-12-31$1.32bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure1,375Total assets, Q1 FY2025, at 2025-03-31$1.38bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure1,452Total assets, Q2 FY2025, at 2025-06-30$1.45bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-31, accession 0001625297-25-000050.Report this figure1,416Total assets, Q3 FY2025, at 2025-09-30$1.42bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure1,201Total assets, FY2025, at 2025-12-31$1.20bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure1,197Total assets, Q1 FY2026, at 2026-03-31$1.20bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure1,233Total assets, Q2 FY2026, at 2026-06-30$1.23bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure1,332Total assets, Q3 FY2026, at 2026-09-30$1.33bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Current liabilities$m1,281Current liabilities, FY2023, at 2023-12-31$1.28bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figurenot reportednot reportednot reported924Current liabilities, FY2024, at 2024-12-31$924.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure1,005Current liabilities, Q1 FY2025, at 2025-03-31$1.00bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure1,056Current liabilities, Q2 FY2025, at 2025-06-30$1.06bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-31, accession 0001625297-25-000050.Report this figure965Current liabilities, Q3 FY2025, at 2025-09-30$965.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure914Current liabilities, FY2025, at 2025-12-31$914.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure779Current liabilities, Q1 FY2026, at 2026-03-31$779.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure868Current liabilities, Q2 FY2026, at 2026-06-30$868.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure1,301Current liabilities, Q3 FY2026, at 2026-09-30$1.30bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Total liabilities$m1,942Total liabilities, FY2023, at 2023-12-31$1.94bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figurenot reportednot reportednot reported1,652Total liabilities, FY2024, at 2024-12-31$1.65bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure1,660Total liabilities, Q1 FY2025, at 2025-03-31$1.66bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure1,709Total liabilities, Q2 FY2025, at 2025-06-30$1.71bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-31, accession 0001625297-25-000050.Report this figure1,623Total liabilities, Q3 FY2025, at 2025-09-30$1.62bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure1,300Total liabilities, FY2025, at 2025-12-31$1.30bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure1,341Total liabilities, Q1 FY2026, at 2026-03-31$1.34bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure1,441Total liabilities, Q2 FY2026, at 2026-06-30$1.44bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure1,392Total liabilities, Q3 FY2026, at 2026-09-30$1.39bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Long-term debt$m237Long-term debt, FY2023, at 2023-12-31$237.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-03, accession 0001625297-25-000016.Report this figurenot reportednot reportednot reported315Long-term debt, FY2024, at 2024-12-31$315.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure311Long-term debt, Q1 FY2025, at 2025-03-31$311.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure308Long-term debt, Q2 FY2025, at 2025-06-30$308.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-07-31, accession 0001625297-25-000050.Report this figure304Long-term debt, Q3 FY2025, at 2025-09-30$304.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure290Long-term debt, FY2025, at 2025-12-31$290.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure486Long-term debt, Q1 FY2026, at 2026-03-31$486.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure487Long-term debt, Q2 FY2026, at 2026-06-30$487.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure0.0Long-term debt, Q3 FY2026, at 2026-09-30$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Current portion of debt$m3.0Current portion of debt, FY2023, at 2023-12-31$3.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-03, accession 0001625297-25-000016.Report this figurenot reportednot reportednot reported18.0Current portion of debt, FY2024, at 2024-12-31$18.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure18.0Current portion of debt, Q1 FY2025, at 2025-03-31$18.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure18.0Current portion of debt, Q2 FY2025, at 2025-06-30$18.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-07-31, accession 0001625297-25-000050.Report this figure18.0Current portion of debt, Q3 FY2025, at 2025-09-30$18.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure29.0Current portion of debt, FY2025, at 2025-12-31$29.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure0.0Current portion of debt, Q1 FY2026, at 2026-03-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure0.0Current portion of debt, Q2 FY2026, at 2026-06-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure488Current portion of debt, Q3 FY2026, at 2026-09-30$488.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure
Shareholders' equity$m(184)Shareholders' equity, FY2023, at 2023-12-31−$184.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001628280-26-012237.Report this figure(161)Shareholders' equity, period not labelled, at 2024-03-31−$161.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure(281)Shareholders' equity, period not labelled, at 2024-06-30−$281.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure(310)Shareholders' equity, period not labelled, at 2024-09-30−$310.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure(337)Shareholders' equity, FY2024, at 2024-12-31−$337.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure(285)Shareholders' equity, Q1 FY2025, at 2025-03-31−$285.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure(257)Shareholders' equity, Q2 FY2025, at 2025-06-30−$257.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure(207)Shareholders' equity, Q3 FY2025, at 2025-09-30−$207.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure(98.0)Shareholders' equity, FY2025, at 2025-12-31−$98.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure(144)Shareholders' equity, Q1 FY2026, at 2026-03-31−$144.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure(208)Shareholders' equity, Q2 FY2026, at 2026-06-30−$208.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure(60.0)Shareholders' equity, Q3 FY2026, at 2026-09-30−$60.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure

Cash flow

Operating cash flow$97.0m, Q3 FY2026
Capital expenditure$14.0m, Q3 FY2026
Share repurchases$0, Q3 FY2026
Indivior Pharmaceuticals, Inc., cash flow, quarterly
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Operating cash flow$m(37.0)Operating cash flow, period not labelled, three months to 2024-03-31−$37.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure88.0Operating cash flow, period not labelled, three months to 2024-06-30$88.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-31, accession 0001625297-25-000050. Derived: 6-month figure less the 3-month figure.Report this figure2.0Operating cash flow, period not labelled, three months to 2024-09-30$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001628280-25-047530. Derived: 9-month figure less the 6-month figure.Report this figure(17.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$17.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure75.0Operating cash flow, Q1 FY2025, three months to 2025-03-31$75.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure158Operating cash flow, Q2 FY2025, three months to 2025-06-30$158.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001628280-26-051895. Derived: 6-month figure less the 3-month figure.Report this figure(39.0)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$39.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001628280-26-068013. Derived: 9-month figure less the 6-month figure.Report this figure(221)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$221.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure(9.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$9.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure229Operating cash flow, Q2 FY2026, three months to 2026-06-30$229.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001628280-26-051895. Derived: 6-month figure less the 3-month figure.Report this figure97.0Operating cash flow, Q3 FY2026, three months to 2026-09-30$97.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001628280-26-068013. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m2.0Capital expenditure, period not labelled, three months to 2024-03-31$2.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure4.0Capital expenditure, period not labelled, three months to 2024-06-30$4.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-31, accession 0001625297-25-000050. Derived: 6-month figure less the 3-month figure.Report this figure7.0Capital expenditure, period not labelled, three months to 2024-09-30$7.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001628280-25-047530. Derived: 9-month figure less the 6-month figure.Report this figure16.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$16.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure5.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$5.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure17.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$17.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001628280-26-051895. Derived: 6-month figure less the 3-month figure.Report this figure20.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$20.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001628280-26-068013. Derived: 9-month figure less the 6-month figure.Report this figure24.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$24.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure20.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$20.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure7.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$7.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001628280-26-051895. Derived: 6-month figure less the 3-month figure.Report this figure14.0Capital expenditure, Q3 FY2026, three months to 2026-09-30$14.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001628280-26-068013. Derived: 9-month figure less the 6-month figure.Report this figure
Share repurchases$m36.0Share repurchases, period not labelled, three months to 2024-03-31$36.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure35.0Share repurchases, period not labelled, three months to 2024-06-30$35.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-07-31, accession 0001625297-25-000050. Derived: 6-month figure less the 3-month figure.Report this figure52.0Share repurchases, period not labelled, three months to 2024-09-30$52.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-30, accession 0001628280-25-047530. Derived: 9-month figure less the 6-month figure.Report this figure50.0Share repurchases, Q4 FY2024, three months to 2024-12-31$50.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure11.0Share repurchases, Q1 FY2025, three months to 2025-03-31$11.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-03, accession 0001628280-26-051895. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-10-29, accession 0001628280-26-068013. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0001628280-26-012237. Derived: 12-month figure less the 9-month figure.Report this figure125Share repurchases, Q1 FY2026, three months to 2026-03-31$125.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure177Share repurchases, Q2 FY2026, three months to 2026-06-30$177.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-03, accession 0001628280-26-051895. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2026, three months to 2026-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-10-29, accession 0001628280-26-068013. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)122.00m, Q3 FY2026
Indivior Pharmaceuticals, Inc., shares, quarterly
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Diluted shares (weighted)m shares137Diluted shares (weighted), period not labelled, three months to 2024-03-31137,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0001625297-25-000030.Report this figure135Diluted shares (weighted), period not labelled, three months to 2024-06-30135,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-31, accession 0001625297-25-000050.Report this figure133Diluted shares (weighted), period not labelled, three months to 2024-09-30133,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0001628280-25-047530.Report this figure125Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31125,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure126Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30126,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure129Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30129,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure129Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31129,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001628280-26-028850.Report this figure124Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30124,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001628280-26-051895.Report this figure122Diluted shares (weighted), Q3 FY2026, three months to 2026-09-30122,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure

Shares outstanding: 118.04mShares outstanding, period not labelled, at 2026-10-09118,035,272 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-10-29, accession 0001628280-26-068013.Report this figure at Oct 9, 2026, from the cover of the 10-Q filed Oct 29, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 08:21 ET. Listed shows no prices and gives no investment advice.